EPAS1 and obesity disorder: Furthermore, it has been reported that HIF1α inhibitor PX-478 and HIF2α inhibitors PT2385 and PT2399 prevent diet-induced obesity and liver steatosis, accompanied by an induction of thermogenic gene expression in adipose tissues51–53.